Evaluation of mHealth Intervention to Promote HIV Prevention and Overcome Stigma Among Transgender Women (EMPOW.HER)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-29
SponsorInstitute of HIV Research and Innovation Foundation, Thailand

About this trial

This study aims to develop and evaluate a multi-component mHealth intervention (mHC and FRESH) to reduce HIV-related and intersectional stigma and improve PrEP use among HIV-negative young transgender women (TGW) in Thailand.

Eligibility criteria

Qualifiers

Age 18-29 years

Male sex at birth

Self-identify as transgender woman/female spectrum

HIV-negative (laboratory confirmed)

Disqualifiers

Serious cognitive or psychiatric condition affecting consent

Active suicidal ideation or major mental illness

Medical contraindications to PrEP

Enrolled in another HIV intervention study

Trial design

Treatments tested in this trial

  • Mobile Healthy Choices (mHC)+SPC
  • FRESH + SPC
  • mHC + FRESH + SPC

Treatment groups

108 Participants
are divided into 4 treatment groups

Sponsors and collaborators